The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
CASTLE BIOSCIENCES | COM | 14843C105 | 485,615 | 22,503 | SH | SOLE | 22,503 | 0 | 0 | ||
SAGIMET BIOSCIENCES | COM SER A | 786700104 | 309,970 | 57,190 | SH | SOLE | 57,190 | 0 | 0 | ||
CARGO THERAPEUTICS | COM | 14179K101 | 19,033,259 | 822,171 | SH | SOLE | 822,171 | 0 | 0 | ||
PYXIS ONCOLOGY | COMMON STOCK | 747324101 | 124,745 | 69,303 | SH | SOLE | 69,303 | 0 | 0 |